Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:07 PM
Ignite Modification Date: 2025-12-25 @ 8:39 PM
NCT ID: NCT02320669
Description: Definitions were adopted from Pediatric Heart Network criteria
Frequency Threshold: 5
Time Frame: 30 days after receiving study medication
Study: NCT02320669
Study Brief: Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Triostat Active Medication - Synthetic Thyroid Hormone Triostat: Bolus of Triiodothyronine followed by infusion for 48 hours 6 None 11 110 17 110 View
Placebo Placebo Control Placebo: Bolus of Placebo followed by infusion for 48 hours 3 None 11 110 20 110 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Sentinel SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cardiac Arrhythmia SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (10.0) View